trial evidence for thrombolysis in MI
Last reviewed 01/2018
The trial evidence for the use of thrombolysis in myocardial infarction is categorised according to the drug used:
- streptokinase
- tissue plasminogen activator
- APSAC
streptokinase in myocardial infarction